🇺🇸 FDA
Patent

US 8163775

Allosteric modulators of metabotropic glutamate receptors

granted A61PA61P25/00A61P25/14

Quick answer

US patent 8163775 (Allosteric modulators of metabotropic glutamate receptors) held by Addex Pharma, S.A. expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/18